TWI280242B - Pharmaceutical compounds - Google Patents
Pharmaceutical compounds Download PDFInfo
- Publication number
- TWI280242B TWI280242B TW089125715A TW89125715A TWI280242B TW I280242 B TWI280242 B TW I280242B TW 089125715 A TW089125715 A TW 089125715A TW 89125715 A TW89125715 A TW 89125715A TW I280242 B TWI280242 B TW I280242B
- Authority
- TW
- Taiwan
- Prior art keywords
- benzo
- ethyl
- carboxylic acid
- morphine
- dimethylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/46—Phenazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9928542.1A GB9928542D0 (en) | 1999-12-02 | 1999-12-02 | Pharmaceutical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
TWI280242B true TWI280242B (en) | 2007-05-01 |
Family
ID=10865607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW089125715A TWI280242B (en) | 1999-12-02 | 2000-12-02 | Pharmaceutical compounds |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1240148A1 (xx) |
JP (1) | JP2003518103A (xx) |
KR (1) | KR100767613B1 (xx) |
CN (1) | CN1304380C (xx) |
AU (1) | AU784397B2 (xx) |
BR (1) | BR0016093A (xx) |
CA (1) | CA2392873A1 (xx) |
GB (2) | GB9928542D0 (xx) |
HK (1) | HK1046133B (xx) |
HU (1) | HUP0300392A3 (xx) |
MX (1) | MXPA02005476A (xx) |
MY (1) | MY136029A (xx) |
PL (1) | PL356482A1 (xx) |
TW (1) | TWI280242B (xx) |
WO (1) | WO2001046157A1 (xx) |
ZA (1) | ZA200204296B (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2433071A (en) * | 2005-12-05 | 2007-06-13 | Kontrakt Technology Ltd | Organic acids comprising planar conjugated heterocyclic molecular system, & photoelectric layer thereof with rodlike supramolecules for use in solar cell |
CN102898388B (zh) * | 2012-09-26 | 2014-12-03 | 浙江工业大学 | 一种合成取代苯并[α]吩嗪类化合物的方法 |
CN103360329B (zh) * | 2013-07-18 | 2015-11-18 | 中国科学院南海海洋研究所 | 一类吩嗪化合物及其在制备抗肿瘤药物中的应用 |
CN106554321B (zh) * | 2015-09-25 | 2019-05-28 | 陆源 | 一种吩嗪类物质、其制备方法及其应用 |
CN113461623A (zh) * | 2021-07-14 | 2021-10-01 | 长江大学 | 一种抗病毒化合物及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5696131A (en) * | 1993-01-22 | 1997-12-09 | Xenova Limited | Treatment of cancers |
AU691787B2 (en) * | 1992-05-28 | 1998-05-28 | Xenova Limited | Treatment of cancers |
PL332416A1 (en) * | 1996-09-23 | 1999-09-13 | Rutgers | Substituted heterocyclic compounds as anticarcinogenic agents |
WO1998045272A1 (en) * | 1997-04-07 | 1998-10-15 | Latrobe University | Topoisomerase inhibitors |
-
1999
- 1999-12-02 GB GBGB9928542.1A patent/GB9928542D0/en not_active Ceased
-
2000
- 2000-12-01 HU HU0300392A patent/HUP0300392A3/hu unknown
- 2000-12-01 CN CNB008187096A patent/CN1304380C/zh not_active Expired - Fee Related
- 2000-12-01 WO PCT/GB2000/004609 patent/WO2001046157A1/en active Application Filing
- 2000-12-01 KR KR1020027007033A patent/KR100767613B1/ko not_active IP Right Cessation
- 2000-12-01 PL PL00356482A patent/PL356482A1/xx not_active Application Discontinuation
- 2000-12-01 GB GB0215275A patent/GB2373499B/en not_active Expired - Fee Related
- 2000-12-01 CA CA002392873A patent/CA2392873A1/en not_active Abandoned
- 2000-12-01 MX MXPA02005476A patent/MXPA02005476A/es not_active Application Discontinuation
- 2000-12-01 EP EP00979799A patent/EP1240148A1/en not_active Withdrawn
- 2000-12-01 AU AU17184/01A patent/AU784397B2/en not_active Ceased
- 2000-12-01 BR BR0016093-8A patent/BR0016093A/pt not_active IP Right Cessation
- 2000-12-01 MY MYPI20005670A patent/MY136029A/en unknown
- 2000-12-01 JP JP2001547068A patent/JP2003518103A/ja active Pending
- 2000-12-02 TW TW089125715A patent/TWI280242B/zh not_active IP Right Cessation
-
2002
- 2002-05-29 ZA ZA200204296A patent/ZA200204296B/en unknown
- 2002-10-10 HK HK02107392.7A patent/HK1046133B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB0215275D0 (en) | 2002-08-14 |
HK1046133B (zh) | 2005-04-15 |
HUP0300392A2 (hu) | 2003-07-28 |
HUP0300392A3 (en) | 2003-09-29 |
ZA200204296B (en) | 2003-05-29 |
GB2373499B (en) | 2004-11-17 |
CN1304380C (zh) | 2007-03-14 |
AU1718401A (en) | 2001-07-03 |
GB9928542D0 (en) | 2000-02-02 |
PL356482A1 (en) | 2004-06-28 |
WO2001046157A1 (en) | 2001-06-28 |
KR100767613B1 (ko) | 2007-10-19 |
HK1046133A1 (en) | 2002-12-27 |
MXPA02005476A (es) | 2003-09-22 |
BR0016093A (pt) | 2002-08-20 |
MY136029A (en) | 2008-07-31 |
KR20020070305A (ko) | 2002-09-05 |
GB2373499A (en) | 2002-09-25 |
CA2392873A1 (en) | 2001-06-28 |
JP2003518103A (ja) | 2003-06-03 |
AU784397B2 (en) | 2006-03-23 |
EP1240148A1 (en) | 2002-09-18 |
CN1433406A (zh) | 2003-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109475528A (zh) | 用于egfr降解的双功能分子和使用方法 | |
CN108601781B (zh) | 作为检测点激酶1(chk1)抑制剂的3,5-二取代吡唑及其制备及应用 | |
WO2016192586A1 (zh) | 氘代脱氢苯基阿夕斯丁类化合物及其制备方法和在制备抗肿瘤的药物中的应用 | |
CN111051300B (zh) | 作为组蛋白脱乙酰基酶1和/或2(hdac1-2)的选择性抑制剂的新杂芳基酰胺衍生物 | |
WO2017114509A1 (zh) | 醛基类化合物及其制法和用途 | |
TW200808771A (en) | Novel compounds II | |
TW201004939A (en) | Novel compounds | |
KR20140006768A (ko) | Lsd1의 아릴사이클로프로필아민 기반 디메틸라아제 억제제 및 이의 의학적 이용 | |
TW200412957A (en) | Therapeutic agents | |
TW200815398A (en) | A novel indazole derivative having spirocyclic structure in the side chain | |
TW200804342A (en) | Trisubstituted amine compound | |
TW201120010A (en) | Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands | |
TW201113272A (en) | Novel pyrimidine-and triazine hepcidine antagonists | |
TW201043603A (en) | Substituted phenylureas and phenylamides as vanilloid receptor ligands | |
TW201742858A (zh) | 苯基丙醯胺類衍生物、其製備方法及其在醫藥上的應用 | |
TW200817405A (en) | Pyrro[1,2-b]pyridazinone compounds | |
TW200906394A (en) | Tetrahydroindole and tetrahydroindazole derivatives | |
JP6797923B2 (ja) | Alkおよびsrpk阻害剤ならびに使用方法 | |
WO2018153293A1 (zh) | 二噁烷并喹唑啉与二噁烷并喹啉类化合物及其制备方法与应用 | |
TW201024285A (en) | Sphingosine-1-phosphate receptor antagonists | |
TW200418825A (en) | Novel (R)-and (S) enantiomers of thiophene hydroxamic acid derivatives | |
TW201103940A (en) | Inhibitors of HIV replication | |
DE102004061746A1 (de) | Alkinyl-substituierte Thiophene | |
TW200811135A (en) | NK-1 and serotonin transporter inhibitors | |
EA037264B1 (ru) | Гетероциклическое сульфонамидное производное и содержащее его лекарственное средство |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |